Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

25 Sep 2020 13:02

RNS Number : 1802A
Collagen Solutions PLC
25 September 2020
 

 

 

Collagen Solutions plc

("Collagen" or the "Company")

 

Notice of AGM

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it is today posting a circular (the "Circular") to shareholders containing the notice of Annual General Meeting ("AGM").

 

The AGM will be held at the Company's offices at 3 Robroyston Oval, Nova Business Park, Glasgow G33 1AP at 11.00 a.m. (UK time) on 23 October 2020, however, as a result of the current COVID-19 pandemic and the legislative measures and associated guidance introduced by the UK and Scottish Governments in response, for the safety of our Shareholders, our employees, our advisers and the general public, the AGM will be held as a closed meeting.

 

Attendance by Shareholders at the AGM in person will not be possible and Shareholders or their appointed proxies (other than the chairman of the AGM) will not be permitted entry to the AGM. Further information on the arrangements for the AGM are set out in the Circular.

 

In the light of these measures the Directors of the Company strongly encourage shareholders to vote by proxy on all of the matters of business by appointing the Chairman of the Meeting as their proxy by submitting a proxy appointment in accordance with the instructions in the Circular and the proxy form.

 

Offer by Rosen's Diversified, Inc

On 27 August 2020, the Boards of Directors of the Company and Rosen's Diversified, Inc ("RDI") announced that agreement had been reached on the terms of a recommended cash offer by RDI for the entire issued and to be issued share capital of the Company not already owned by RDI (the "Offer"). The offer document containing the full terms and conditions of the Offer and the related form of acceptance were published on 14 September 2020.

 

The AGM is being convened in view of the Company's obligations under the Companies Act 2006. Whether or not you have accepted or intend to accept the Offer, you are still entitled to vote at the AGM, provided that you remain on the register of members of the Company at the relevant time. Where you have accepted the Offer before the AGM, your vote at the AGM will still be counted if: (i) you have followed the instructions set out in the notice of AGM and (where applicable) the accompanying form of proxy; and (ii) you are registered in the register of members of the Company at close of trading on 21 October 2020 (or, in the event of any adjournment of the AGM, on the date which is two days before the time of the adjourned meeting). Changes to the register of members after the relevant deadline, whether as a result of acceptance of the Offer or otherwise, shall be disregarded in determining the rights of any person to vote at the meeting.

 

Annual report and accounts for the year ended 31 March 2020

On 31 July 2020, the Company announced its unaudited results for the year ended 31 March 2020. The Company had previously announced on 15 June 2020 that it had been granted an extension to the filing deadline for its audited consolidated accounts for the year ended 31 March 2020 to 31 December 2020 in light of the ongoing COVID-19 pandemic. Accordingly, the audited consolidated accounts for the year ended 31 March 2020 and the directors' reports thereon are not enclosed with the Circular and will not be laid before the AGM.

 

Collagen Solutions Plc

Via Walbrook

Jamal Rushdy, CEO

Hilary Spence, CFO

Cenkos Securities Plc (Nominated Adviser and Broker)

Giles Balleny (Corporate Finance)

Tel: 0207 397 8900

Stephen Keys

Walbrook PR Ltd

Tel: 020 7933 8780 or collagen@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAEAANSAEEEEFA
Date   Source Headline
10th Mar 20152:56 pmRNSDirector/PDMR Shareholding
10th Mar 20157:03 amRNSRegulatory Approvals for Collagen Solutions Client
10th Mar 20157:03 amRNSTrading Statement and Acquisition Update
9th Jan 20157:00 amRNSInvestor Presentation
7th Jan 20154:04 pmRNSHolding(s) in Company
7th Jan 20157:00 amRNSCEO Presents at OneMedForum
5th Jan 20157:00 amRNSContract signed with Globus Medical Inc.
22nd Dec 20147:00 amRNSNew contract to supply Desu Medical
17th Dec 201410:54 amRNSHolding(s) in Company
15th Dec 20147:00 amRNSContract signed with Kyeron
12th Dec 201410:50 amRNSHolding(s) in Company
10th Dec 20147:00 amRNSSouthern Lights Biomaterials Acquisition Completed
24th Nov 201411:48 amRNSGrant of Options
21st Nov 20147:30 amRNSSchedule 1 - Collagen Solutions Plc
21st Nov 20147:00 amRNSAcquisition
21st Nov 20147:00 amRNSChange of Adviser
21st Nov 20147:00 amRNSHalf Yearly Report
22nd Oct 201412:30 pmRNSHolding(s) in Company
17th Oct 20147:00 amRNSJellagen Collaboration
10th Sep 201412:23 pmRNSHolding(s) in Company
3rd Sep 20147:00 amRNSAppointment to Scientific Advisory Board
27th Aug 201411:52 amRNSResult of AGM
29th Jul 20143:19 pmRNSHolding(s) in Company
18th Jul 20147:00 amRNSPosting of Annual Report & Notice of AGM
10th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSChange of Registered Office
10th Jun 20147:00 amRNSExclusive Licencing of Intellectual Property
19th May 20147:00 amRNSProfessor Robert Brown joins as Scientific Adviser
15th May 20147:00 amRNSExcellagen® enters new clinical trial
26th Mar 201410:48 amRNSHolding(s) in Company
3rd Mar 20147:00 amRNSAppointment of Director
27th Dec 201312:25 pmRNSDirector Shareholding
27th Dec 201311:58 amRNSResult of GM
17th Dec 201310:00 amRNSAnnouncement by Cardium Therapeutics
16th Dec 20139:03 amRNSSchedule 1 - Healthcare Investment Opportunities
10th Dec 20137:00 amRNSHalf Yearly Report
10th Dec 20137:00 amRNSProposed acquisition
19th Aug 201311:06 amRNSHolding(s) in Company
1st Aug 20131:43 pmRNSHolding(s) in Company
2nd May 201312:00 pmRNSHolding(s) in Company
22nd Apr 201312:19 pmRNSHolding(s) in Company
9th Apr 201310:57 amRNSHolding in Company
8th Apr 20135:41 pmRNSHolding(s) in Company
5th Apr 20137:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.